An interventional study of Education - Diabetes and Social Issues in Diabetes Mellitus, sponsored by Forschungsinstitut der Diabetes Akademie Mergentheim. Completed at 4 sites in Germany. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-08-09.
Sponsored by Forschungsinstitut der Diabetes Akademie Mergentheim · Not applicable, Interventional, and Treatment
This study is a multi-center, randomized prospective trial with a 6-month follow up. A newly developed treatment and education module will be tested compared to a waiting-list control group. The module covers the topic "diabetes and social issues". Primary outcome variable is diabetes-specific empowerment regarding diabetes and social issues. Secondary outcome variables are: diabetes-related distress, health-related quality of life, depressive symptoms, self-care behavior, and glycemic control.
The module consists of one lesson (duration: 90 minutes). The module is derived from the empowerment approach and is based on the previously evaluated education and treatment program for type 1 diabetes: PRIMAS (NCT01220557). The module is designed as a group session held by a trained diabetes educator. Patients are randomized either to the immediate participation in the module or to the control group. Control group is a waiting-list control group. Patients in this waiting-list control group get the education after the completion of the 6-month follow-up.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
This study's enrollment of 256 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →Forschungsinstitut der Diabetes Akademie Mergentheim is the lead sponsor of 14 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients randomized to this arm, will participate immediately in the education module "Diabetes and Social Issues"
Behavioral: Education - Diabetes and Social Issues
Patients in the control group will get the education with the education module after completion of the 6-month follow-up
Based on the treatment and education programme PRIMAS a problem-specific education module regarding "Diabetes and Social Issues" was created. The module covers specific and detailed aspects of the topic "social issues" such as driver licence, hypoglycemia when driving, and the pass for severly handicapped persons. With this module, a more comprehensive education of patients with specific interest is possible.
Change from baseline in diabetes-specific empowerment on the adapted Diabetes Empowerment Scale at the 2-week and 6-month follow-up
The Diabetes Empowerment Scale was specifically adjusted to cover the topic "social issues". Psychometric criteria for these adjusted scale were evaluated in an independent study
Time frame: Baseline, 2-week follow-up , 6-month follow-up
Change from baseline in problem-specific distress on the adapted Problem Areas in Diabetes (PAID) Scale at the 2-week and 6-month follow-up
The PAID scale was specifically adapted to cover the topic "social issues". Psychometric quality was assessed in an independent study
Time frame: baseline, 2-week follow-up, 6-month follow-up
Change from baseline in glycemic control (HbA1c) at the 2-week and 6-month follow-up
HbA1c will be analyzed in a central laboratory.
Time frame: baseline, 2-week follow-up, 6-month follow-up
Change from baseline in health-related quality of life on the EQ-5D at the 2-week and 6-month follow-up
Time frame: baseline, 2-week follow-up, 6-month follow-up
Change from baseline in quality of life on the WHO-5 at the 2-week and 6-month follow-up
Time frame: baseline, 2-week follow-up, 6-month follow-up
Change from baseline in self-efficacy on the General Self-Efficacy Scale (GSE) the 2-week and 6-month follow-up
Time frame: baseline, 2-week follow-up, 6-month follow-up
Change from baseline in general diabetes-distress at the 2-week and 6-month follow-up
Time frame: baseline, 2-week follow-up, 6-month follow-up
Change from baseline in depressive symptoms on the CES-D at the 2-week and 6-month follow-up
Time frame: baseline, 2-week follow-up, 6-month follow-up
This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Forschungsinstitut der Diabetes Akademie Mergentheim